Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial ribosome 30S subunit is a ribonucleoprotein complex essential for protein synthesis in prokaryotic cells. It comprises a 16S ribosomal RNA molecule and 21 distinct ribosomal proteins (S1-S21). The 30S subunit plays a critical role in decoding mRNA, ensuring translational fidelity, and initiating protein synthesis. It is a major target for several clinically important antibiotics that disrupt bacterial protein synthesis by interfering with its function. Its structure contains key functional sites such as the decoding center, the P-site, and the D-site.
Inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit, interfering with tRNA binding, mRNA decoding, or translocation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Ribosome 30S Subunit Protein Synthesis Machinery (30S Ribosomal Subunit).